Serum ProGRP demonstrated significantly higher values for AUC, sensitivity, and specificity in diagnosing SCLC than serum NSE, indicating that ProGRP is a better diagnostic marker for SCLC than NSE. This evidence concerns the gene ENO2 and small cell lung carcinoma.